< Back to previous page
Researcher
Wim Wuyts
- Disciplines:Respiratory medicine
Affiliations
- Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE) (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 8 of 8
- Co-designing a Core Outcome Set for and with patients with Idiopathic Pulmonary Fibrosis (COCOS-IPF)From1 Jun 2022 → TodayFunding: FWO research project
- Implementation of a multimodal screening program for interstitial lung disease in rheumatoid arthritis patientsFrom29 Sep 2021 → TodayFunding: FWO fellowships
- Early detection of Pulmonary fibrosis by analysis of breathing soundsFrom21 Jan 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Implementation of a standardized screening program for IPF patients and relatives in FlandersFrom1 Jan 2021 → TodayFunding: FWO Applied Biomedical Research (TBM)
- A study on the loss of small airways and epithelial cell changes in chronic lung diseasesFrom15 Oct 2019 → TodayFunding: FWO fellowships
- Small airway homeostasis, the Achilles heel of the lung driving chronic lung disease?From1 Oct 2019 → TodayFunding: IOF - technology concept exploration, BOF - projects
- Rethinking IPF care: charting the course to person-centred integrated care for idiopathic pulmonary fibrosis together with patients and healthcare professionalsFrom14 Feb 2018 → 23 Mar 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- A multidisciplinary approach for a better diagnosis and understanding of idiopathic pulmonary fibrosis.From1 Sep 2009 → 30 Sep 2009Funding: BOF - Bilateral scientific cooperation
Publications
1 - 10 of 197
- FOSL2 truncating variants in the last exon cause a neurodevelopmental disorder with scalp and enamel defects.(2022)
Authors: Isabelle Meyts, Wim Wuyts, Selket Delafontaine, Kris Van Den Bogaert, Koenraad Devriendt
Pages: 2475 - 2486 - The 6-min walk test as a primary end-point in interstitial lung disease(2022)
Authors: Wim Wuyts
- Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis An International Working Group Perspective(2022)
Authors: Wim Wuyts
Pages: 247 - 259 - Outbreak of Silicosis in Workers Producing Artificial Stone Skirting Boards A Novel Application of Silica-Based Composites(2022)
Authors: Steven Ronsmans, Birgit Weynand, Peter Hoet, Jeroen Vanoirbeek, Wim Wuyts, Benoit Nemery de Bellevaux
Pages: 406 - 409 - BAL Transcriptomes Characterize Idiopathic Pulmonary Fibrosis Endotypes With Prognostic Impact(2022)
Authors: Laurens De Sadeleer, Tinne Goos, Wim Wuyts
Pages: 1576 - 1588 - Electronically monitored medication adherence in idiopathic pulmonary fibrosis: prevalence, predictors and outcomes(2022)
Authors: Anouk Delameillieure, Wim Wuyts
- The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome(2022)
Authors: Tinne Goos, Laurens De Sadeleer, Arno Vanstapel, Janne Kaes, Vincent Geudens, Diether Lambrechts, Sascha Vermeer, Laurens Ceulemans, Dirk Van Raemdonck, Laurent Godinas, et al.
- Behavioural and psychological patterns of patients with idiopathic pulmonary fibrosis: a prospective study(2022)
Authors: Anouk Delameillieure, Fabienne Dobbels, Steffen Fieuws, Wim Wuyts
- Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial)(2022)
Authors: Wim Wuyts
Pages: 1084 - 1092 - Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry(2022)
Authors: Wim Wuyts
Pages: 181 - 194